Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Cannabis Use Disorder Market Forecast: What Market Value Is Expected By 2030?
The market for cannabis use disorder is experiencing robust expansion, projected to increase from $1.65 billion in 2025 to $1.78 billion in 2026, reflecting a compound annual growth rate of 7.5%. This upward trajectory in the historical period is underpinned by several key factors, including a growing tendency towards cannabis consumption, heightened consciousness surrounding substance use disorders, the expansion of treatment facilities, increased acknowledgment of mental health conditions, and the availability of therapeutic approaches for behavioral change.
The market for cannabis use disorder is poised for substantial expansion in the upcoming years, projected to reach $2.35 billion by 2030 with a compounded annual growth rate of 7.3%. This anticipated growth stems from several key factors, including the heightened embrace of digital mental health services, escalating investments in addiction research, broader implementation of telehealth treatment frameworks, a greater emphasis on results-driven care, and the seamless incorporation of both medication and behavioral therapies. Key developments anticipated during this forecast period involve a surge in the adoption of combined behavioral and pharmaceutical interventions, intensified attention on individualized addiction treatment plans, increased utilization of digital therapeutics and remote patient monitoring, the wider deployment of comprehensive, multi-disciplinary care strategies, and a strengthened focus on identifying and addressing addiction at its earliest stages.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21126&type=smp
Cannabis Use Disorder Market Industry Drivers: What Is Driving Revenue Growth?
Enhanced recognition and identification of cannabis dependency are anticipated to spur advancements within the cannabis use disorder market. Such heightened awareness and diagnostic efforts encompass educating the general populace, medical practitioners, and individuals concerning the indicators, manifestations, and hazards associated with cannabis use disorder. This surge in awareness and diagnosis is attributable to a confluence of elements, including the expanding legalization and accessibility of cannabis, alongside growing scientific and medical validation of its impacts. The therapeutic interventions for cannabis use disorder present a systematic methodology for mitigating withdrawal symptoms, curbing cravings, and addressing underlying psychological elements, thereby directly bolstering the diagnosis of cannabis addiction by furnishing empirical evidence of dependence patterns, underscoring the disorder’s seriousness, and dictating the suitable intervention level according to an individual’s distinct requirements. Illustratively, in November 2024, data from The Office for Health Improvement and Disparities, a UK governmental body, indicated that the proportion of individuals initiating treatment for cannabis-related concerns remained largely consistent this year, experiencing a marginal increase of 0.5 percentage points, moving from 20.9% to 21.4%. Concurrently, the count of individuals presenting with benzodiazepine-related issues saw an escalation from 3,620 during 2022–2023 to 3,872 in the current year. Consequently, the amplified awareness and more frequent diagnosis of cannabis addiction are acting as key drivers for the expansion of the cannabis use disorder market.
Cannabis Use Disorder Market Segment Analysis Highlighting Growth Areas
The cannabis use disorder market covered in this report is segmented –
1) By Treatment: Pharmacotherapy, Behavioral Therapies
2) By Route Of Administration: Oral, Transdermal, Inhalation, Sublingual
3) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers
Subsegments:
1) By Pharmacotherapy: Cannabinoid-Based Medications, Antidepressants, Anxiolytics (Non-Benzodiazepine), Antipsychotics
2) By Behavioral Therapies: Cognitive Behavioral Therapy (CBT), Contingency Management, Motivational Enhancement Therapy (MET), 12-Step Facilitation Therapy
#Cannabis Use Disorder Market Growth Trends: What Is Influencing The Future Outlook?
Leading entities within the cannabis use disorder (CUD) sector are concentrating their efforts on pioneering innovative approaches, including digital therapeutics and technology-assisted behavioral interventions. These advanced solutions aim to assist individuals in curtailing or ceasing problematic cannabis consumption through structured counseling methodologies, tailored care plans, and continuous support mechanisms. Digital therapeutics, in the context of CUD management, encompass scientifically validated, technology-based programs engineered to administer therapeutic interventions, monitor patient advancement, and facilitate remote interaction with credentialed healthcare providers, thereby enhancing commitment to treatment and fostering sustained recovery. Illustratively, in April of 2024, Pelago, a virtual healthcare provider situated in the United States with expertise in managing substance use disorders, launched a specialized CUD treatment initiative. This program was developed in response to the increasing prevalence of CUD, affecting an estimated 18 million adults in the U.S. Pelago’s offering includes educational content regarding cannabis consumption and incorporates evidence-based therapeutic modalities like cognitive behavioral therapy and motivational enhancement therapy, while also extending its supportive services to adolescents aged 15 to 17, with a focus on achieving abstinence-based treatment objectives.
Cannabis Use Disorder Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the cannabis use disorder market are Lyra Health Inc., Pyramid Healthcare Inc., Hazelden Betty Ford Foundation, Charlie Health, Caron Treatment Center, Promises Behavioral Health, Sierra Tucson, Samarpan, Affect Therapeutics Inc., Cadabam’s Rehabilitation Center, Aelis Farma, Skywood Recovery, Pelago, PleoPharma Inc., Abhasa, Marijuana Anonymous, Northpoint Colorado, Sukoon Health, Granite Mountain Behavioral Healthcare, GreeneStone
Access The Complete Cannabis Use Disorder Market Report:
https://www.thebusinessresearchcompany.com/report/cannabis-use-disorder-global-market-report
#Cannabis Use Disorder Market Largest Region: Which Geography Holds The Highest Market Share?
North Americawas the largest region in the cannabis use disorder market in 2025. The regions covered in the cannabis use disorder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model